Bernard V. Fischbach
Distinguished in Nephrosclerosis

Dr. Bernard V. Fischbach

Nephrology | Internal Medicine
Texas Health Resources
Dallas Nephrology Associates
1250 Eighth Ave, Ste 500, 
Fort Worth, TX 
On Staff At
Offers Telehealth
Distinguished in Nephrosclerosis
Texas Health Resources
Dallas Nephrology Associates
1250 Eighth Ave, Ste 500, 
Fort Worth, TX 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Bernard Fischbach is an Internal Medicine specialist and a Nephrologist in Fort Worth, Texas. Dr. Fischbach is rated as a Distinguished provider by MediFind in the treatment of Nephrosclerosis. His top areas of expertise are Nephrosclerosis, Chronic Kidney Disease, Renovascular Hypertension, Kidney Transplant, and Nephrectomy.

His clinical research consists of co-authoring 14 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Creighton University School Of Medicine - Registrar (1996)
Residency
Creighton University School of Medicine - Medicine (2000)
Specialties
Nephrology
Internal Medicine
Licenses
Internal Medicine in TX
Fellowships
Vanderbilt University (2003)
Vanderbilt University Program - Internal Medicine (2002)
Hospital Affiliations
Texas Health Fort Worth
Texas Health Specialty Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Baylor Scott & White Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Oscar
  • EPO
  • HMO
  • PPO
Scott and White Health
  • HMO
  • POS
Superior Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
TeamCare
  • OTHER COMMERCIAL
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 16 Less Insurance Carriers -

Locations

Dallas Nephrology Associates
1250 Eighth Ave, Ste 500, Fort Worth, TX 76104

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

A Pivotal Phase 3 Trial to Evaluate the Safety and Efficacy of Clazakizumab for the Treatment of Chronic Active Antibody-mediated Rejection in Kidney Transplant Recipients
A Pivotal Phase 3 Trial to Evaluate the Safety and Efficacy of Clazakizumab for the Treatment of Chronic Active Antibody-mediated Rejection in Kidney Transplant Recipients
Enrollment Status: Terminated
Publish Date: July 23, 2025
Intervention Type: Drug, Biological
Study Phase: Phase 3
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
A Phase 2/3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients With Alport Syndrome
Enrollment Status: Completed
Publish Date: June 11, 2025
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
An Extended Access Program to Assess Long Term Safety of Bardoxolone Methyl in Patients With Chronic Kidney Disease
An Extended Access Program to Assess Long Term Safety of Bardoxolone Methyl in Patients With Chronic Kidney Disease
Enrollment Status: Terminated
Publish Date: June 03, 2025
Intervention Type: Drug
Study Drug: Bardoxolone
Study Phase: Phase 3
A Phase 3 Randomized, Open-label (Sponsor-blind), Active-controlled, Parallel-group, Multi-center, Event Driven Study in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Darbepoetin Alfa
A Phase 3 Randomized, Open-label (Sponsor-blind), Active-controlled, Parallel-group, Multi-center, Event Driven Study in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Darbepoetin Alfa
Enrollment Status: Completed
Publish Date: April 02, 2024
Intervention Type: Drug
Study Drugs: Daprodustat, Darbepoetin Alpha
Study Phase: Phase 3
A Repeat Dose, Open Label, Two Period, Randomized, Cross Over Study to Compare the Effect of Daprodustat to Recombinant, Human Erythropoietin (rhEPO) on Oral Iron Absorption in Adult Participants With Anemia Associated With Chronic Kidney Disease Who Are Not on Dialysis
A Repeat Dose, Open Label, Two Period, Randomized, Cross Over Study to Compare the Effect of Daprodustat to Recombinant, Human Erythropoietin (rhEPO) on Oral Iron Absorption in Adult Participants With Anemia Associated With Chronic Kidney Disease Who Are Not on Dialysis
Enrollment Status: Completed
Publish Date: March 27, 2024
Intervention Type: Drug
Study Drugs: Daprodustat, Epoetin Alpha, Ferrous Sulfate
Study Phase: Phase 2
Evaluation of Patient Outcomes From the Kidney Allograft Outcomes AlloSure Registry
Evaluation of Patient Outcomes From the Kidney Allograft Outcomes AlloSure Registry
Enrollment Status: Active_not_recruiting
Publish Date: June 27, 2023
Intervention Type: Diagnostic test, Other
A Phase 3, Multicenter, Randomized, Open-label, Active-controlled Study to Assess the Efficacy and Safety of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment With Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir
A Phase 3, Multicenter, Randomized, Open-label, Active-controlled Study to Assess the Efficacy and Safety of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment With Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir
Enrollment Status: Completed
Publish Date: November 03, 2021
Intervention Type: Drug
Study Phase: Phase 3
A Randomized Double-blind Placebo-controlled Study to Evaluate the Efficacy and Safety of Cinryze® (C1 Esterase Inhibitor [Human]) for the Treatment of Acute Antibody-mediated Rejection in Kidney Transplant Patients
A Randomized Double-blind Placebo-controlled Study to Evaluate the Efficacy and Safety of Cinryze® (C1 Esterase Inhibitor [Human]) for the Treatment of Acute Antibody-mediated Rejection in Kidney Transplant Patients
Enrollment Status: Terminated
Publish Date: July 13, 2020
Intervention Type: Drug, Biological
Study Phase: Phase 3
View 7 Less Clinical Trials

14 Total Publications

Elevated tacrolimus levels among COVID-19 kidney transplant recipients are associated with worse disease severity and clinical outcomes.
Elevated tacrolimus levels among COVID-19 kidney transplant recipients are associated with worse disease severity and clinical outcomes.
Journal: Clinical nephrology
Published: September 07, 2023
View All 14 Publications
Similar Doctors
Daniel S. Richey
Distinguished in Nephrosclerosis
Dr. Daniel S. Richey
Nephrology | Internal Medicine
Distinguished in Nephrosclerosis
Dr. Daniel S. Richey
Nephrology | Internal Medicine

Dallas Nephrology Associates - Fort Worth

1250 8th Ave, Ste 135, 
Fort Worth, TX 
 (0.1 miles away)
817-921-2153
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Daniel Richey is an Internal Medicine specialist and a Nephrologist in Fort Worth, Texas. Dr. Richey is rated as a Distinguished provider by MediFind in the treatment of Nephrosclerosis. His top areas of expertise are Nephrosclerosis, Renovascular Hypertension, Chronic Kidney Disease, and End-Stage Renal Disease (ESRD).

Angelito F. Yango
Distinguished in Nephrosclerosis
Dr. Angelito F. Yango
Nephrology | Internal Medicine
Distinguished in Nephrosclerosis
Dr. Angelito F. Yango
Nephrology | Internal Medicine

Dallas Nephrology Associates - Fort Worth

1250 8th Ave, Ste 135, 
Fort Worth, TX 
 (0.1 miles away)
817-921-2153
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Angelito Yango is an Internal Medicine specialist and a Nephrologist in Fort Worth, Texas. Dr. Yango is rated as an Advanced provider by MediFind in the treatment of Nephrosclerosis. His top areas of expertise are Nephrosclerosis, Acute Kidney Failure, Renovascular Hypertension, Chronic Kidney Disease, and Kidney Transplant.

Distinguished in Nephrosclerosis
Dr. Venkata A. Yalamanchili
Nephrology | Internal Medicine
Distinguished in Nephrosclerosis
Dr. Venkata A. Yalamanchili
Nephrology | Internal Medicine

Dallas Nephrology Associates

2651 Bolton Boone Drive, Drive, 
Desoto, TX 
 (27.7 miles away)
972-780-0480
Experience:
27+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Venkata Yalamanchili is an Internal Medicine specialist and a Nephrologist in Desoto, Texas. Dr. Yalamanchili has been practicing medicine for over 27 years and is rated as a Distinguished provider by MediFind in the treatment of Nephrosclerosis. His top areas of expertise are Nephrosclerosis, Renovascular Hypertension, End-Stage Renal Disease (ESRD), and Chronic Kidney Disease.

VIEW MORE NEPHROSCLEROSIS DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Fischbach's expertise for a condition
ConditionClose
    • Distinguished
    • Chronic Kidney Disease
      Dr. Fischbach is
      Distinguished
      . Learn about Chronic Kidney Disease.
      See more Chronic Kidney Disease experts
    • Nephrosclerosis
      Dr. Fischbach is
      Distinguished
      . Learn about Nephrosclerosis.
      See more Nephrosclerosis experts
    • Renovascular Hypertension
      Dr. Fischbach is
      Distinguished
      . Learn about Renovascular Hypertension.
      See more Renovascular Hypertension experts
    • Advanced
    • Acute Kidney Failure
      Dr. Fischbach is
      Advanced
      . Learn about Acute Kidney Failure.
      See more Acute Kidney Failure experts
    • Alport Syndrome
      Dr. Fischbach is
      Advanced
      . Learn about Alport Syndrome.
      See more Alport Syndrome experts
    • End-Stage Renal Disease (ESRD)
      Dr. Fischbach is
      Advanced
      . Learn about End-Stage Renal Disease (ESRD).
      See more End-Stage Renal Disease (ESRD) experts
    • Kidney Transplant
      Dr. Fischbach is
      Advanced
      . Learn about Kidney Transplant.
      See more Kidney Transplant experts
    • Necrosis
      Dr. Fischbach is
      Advanced
      . Learn about Necrosis.
      See more Necrosis experts
    • Experienced
    • Acute Tubular Necrosis
      Dr. Fischbach is
      Experienced
      . Learn about Acute Tubular Necrosis.
      See more Acute Tubular Necrosis experts
    • Bilateral Hydronephrosis
      Dr. Fischbach is
      Experienced
      . Learn about Bilateral Hydronephrosis.
      See more Bilateral Hydronephrosis experts
    • Boils
      Dr. Fischbach is
      Experienced
      . Learn about Boils.
      See more Boils experts
    • Carbuncle
      Dr. Fischbach is
      Experienced
      . Learn about Carbuncle.
      See more Carbuncle experts
    • Cytomegalic Inclusion Disease
      Dr. Fischbach is
      Experienced
      . Learn about Cytomegalic Inclusion Disease.
      See more Cytomegalic Inclusion Disease experts
    • Cytomegalovirus Infection
      Dr. Fischbach is
      Experienced
      . Learn about Cytomegalovirus Infection.
      See more Cytomegalovirus Infection experts
    View All 19 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.